Agilent Technologies, Inc. · NYSE (us_market)
Healthcare · Diagnostics & Research · United States
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2026-01-09$148.52 RISE2026-05-19$110.57 PEAK2026-05-29$135.53 140d | -25.6% 130d | Missed | Missed | — | — | +22.6% 10d | Missed |
DROP2025-11-25$157.20 RISE2026-03-27$110.24 PEAK2026-05-29$135.53 185d | -29.9% 122d | Missed | Missed | — | — | +22.9% 63d | Missed |
DROP2025-01-22$152.60 RISE2025-04-08$99.29 PEAK2025-07-03$121.38 162d | -34.9% 76d | 2025-04-08 $99.29 | 2025-07-03 $121.38 | 66Quality on Sale | 52Watch | +22.2% 86d | +22.2% Held 86d |
DROP2024-09-30$148.48 RISE2024-11-19$125.69 PEAK2025-01-22$152.60 114d | -15.3% 50d | Missed | Missed | — | — | +21.4% 64d | Missed |
DROP2024-05-20$154.64 RISE2024-07-09$125.42 PEAK2024-09-30$148.48 133d | -18.9% 50d | Missed | Missed | — | — | +18.4% 83d | Missed |
DROP2023-07-26$128.47 RISE2023-10-30$101.17 PEAK2023-12-27$139.82 154d | -21.3% 96d | 2023-10-27 $102.77 | 2023-12-13 $133.74 | 61Quality on Sale | 44Watch | +38.2% 58d | +30.1% Held 47d |
DROP2022-02-09$144.44 RISE2022-06-17$112.71 PEAK2022-08-17$142.29 189d | -22.0% 128d | 2022-05-11 $113.99 | 2022-05-31 $127.56 | 57Quality on Sale | 44Watch | +26.2% 61d | +11.9% Held 20d |
DROP2021-12-30$160.88 RISE2022-05-09$113.11 PEAK2022-08-03$134.56 216d | -29.7% 130d | 2022-05-11 $113.99 | 2022-05-31 $127.56 | 57Quality on Sale | 44Watch | +19.0% 86d | +11.9% Duplicate trade Held 20d |
DROP2020-01-22$90.13 RISE2020-03-23$63.37 PEAK2020-06-04$91.14 134d | -29.7% 61d | Missed | Missed | — | — | +43.8% 73d | Missed |
Check out the companies making headlines this week:
June S&P 500 E-Mini futures (ESM26) are trending up +0.18% this morning as investors became more confident that the U.S. and Iran are nearing a deal.
Agilent Technologies Inc. (NYSE:A) is one of the 11 Stocks Racking Up Monstrous Gains. Agilent Technologies extended its winning streak to a 6th consecutive day on Thursday, as investors resumed buying positions amid a strong earnings performance in the second quarter of fiscal year 2026 and raised growth outlook for the full-year period. In a […]
There's nothing like a beat-and-raise quarter to bring the right kind of attention to a company.
Shares of life sciences tools company Agilent Technologies (NYSE:A) jumped 16.1% in the morning session after the company reported an impressive first quarter (fiscal Q2) results.
The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.58%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.84%. June E-mini S&P futures (ESM26 ) rose +0.59%, and June E-mini Nasdaq futures...
Agilent stock rocketed Thursday after the research tools outfit put up a broad fiscal second-quarter beat and biked its guidance.
Agilent Technologies Inc (NYSE:A) shares climbed 19% on Thursday after the company posted stronger-than-expected fiscal second quarter results and received an upgrade from Bank of America, which pointed to improving demand trends and continued market share gains in key instrument...
Investing.com -- Bank of America upgraded Agilent Technologies to “Buy” from “Neutral,” citing strong execution, market share gains, and resilience across key end markets despite broader concerns in the life sciences tools sector.
A beats Q2 earnings and revenue estimates as recurring revenue hits 66% of sales, but shares lost despite raised fiscal 2026 guidance.
Agilent Technologies stock surges as Wall Street approves of the company’s second-quarter earnings and guidance update.
Agilent Technologies (A) is benefiting from broad-based product cycle momentum and resilient end-mar
Agilent Technologies Inc (A) surpasses revenue and EPS guidance with robust growth across key segments, despite geopolitical and funding challenges.
Agilent Technologies (NYSE:A) raised its fiscal 2026 outlook after reporting stronger-than-expected second-quarter results, with management pointing to broad-based demand, instrument replacement momentum, pricing actions and operational gains from its Ignite operating system. CEO Padraig McDonnell
Tejas Rajeev Savant: Thank you, Corina, and welcome everyone to Agilent's conference call for the rest of the year? With me on the line are CEO, Padraig McDonnell and CFO, Adam S. Elinoff. Q&A will be Simon May, president of the Life Sciences and Diagnostics Markets Group Angelica Riemann, president of the Agilent CrossLab Group and Mike Zhang, president of the Applied Markets Group.
Agilent (A) delivered earnings and revenue surprises of +6.21% and +2.12%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?
Life sciences tools company Agilent Technologies (NYSE:A) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 10% year on year to $1.84 billion. The company expects next quarter’s revenue to be around $1.84 billion, close to analysts’ estimates. Its non-GAAP profit of $1.49 per share was 5.8% above analysts’ consensus estimates.
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Pre-Market Stock Futures: Futures are trading higher as we hit the mid-week point, as the technology-led rally continues to spiral higher. While the major indices finished the day mixed, the technology-heavy Nasdaq led the way once again, closing at a new record high of 26,656, up 1.19%, while the S&P 500 also set a new ... Here Are Wednesday’s Top Wall Street Analyst Research Calls: Agilent, Dollar General, FedEx, GE Aerospace, Hershey, Intuit, SanDisk, Workday, Zscaler, and More
Life sciences tools company Agilent Technologies (NYSE:A) will be reporting results this Wednesday after the bell. Here’s what investors should know.
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| A | +18.35% | +14.69% | -0.40% | +21.10% |
| XLV | +2.97% | -5.72% | -3.44% | +12.69% |
| Alpha (stock − sector) | +15.38% | +20.41% | +3.05% | +8.41% |
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| StateStreet | passive | 12.76M | $1.46B | 0.05% | Added+0.7% | 2026-03-31 |
| Wellington | fundamental | 7.26M | $827.09M | 0.15% | Trimmed-4.4% | 2026-03-31 |
| DEShaw | quant | 1.70M | $193.30M | 0.12% | Added+498.4% | 2026-03-31 |
| FidelityFMR | fundamental | 916.8K | $104.50M | 0.01% | Trimmed-20.4% | 2026-03-31 |
| TwoSigma | quant | 677.3K | $77.20M | 0.06% | Added+155.2% | 2026-03-31 |
| RenTech | quant | 300.3K | $34.23M | 0.05% | New | 2026-03-31 |
| Bridgewater | macro | 73.7K | $8.40M | 0.04% | Added+462.8% | 2026-03-31 |
| TRowePrice | fundamental | 413.0K | $47.08K | 0.01% | Trimmed-4.7% | 2026-03-31 |
| Filed | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-21 | Buckner Michael Steven | Senior Vice President | A Grant / award | 8,872 | — | +$0 |
| 2026-05-12 | MAY SIMON | Senior Vice President | F Tax withholding | 368 | $115.62 | −$42.5K |
| 2026-04-02 | Henson Meghan | Senior Vice President | F Tax withholding | 153 | $113.98 | −$17.4K |
| 2026-03-23 | Anand Mala | Director | A Grant / award | 2,158 | $111.75 | +$241.2K |
| 2026-03-23 | Brown Judy L | Director | A Grant / award | 2,158 | $111.75 | +$241.2K |
| 2026-03-23 | Dolsten Mikael | Director | A Grant / award | 2,158 | $111.75 | +$241.2K |
| 2026-03-23 | KOH BOON HWEE | Director | F Tax withholding | 648 | $111.75 | −$72.4K |
| 2026-03-23 | KOH BOON HWEE | Director | A Grant / award | 2,158 | $111.75 | +$241.2K |
| 2026-03-23 | Podolsky Daniel K | Director | A Grant / award | 2,158 | $111.75 | +$241.2K |
| 2026-03-23 | WILSON DOW R | Director | A Grant / award | 2,158 | $111.75 | +$241.2K |
| 2026-03-23 | Soriot Pascal | Director | F Tax withholding | 648 | $111.75 | −$72.4K |
| 2026-03-23 | Soriot Pascal | Director | A Grant / award | 2,158 | $111.75 | +$241.2K |
| 2026-03-23 | SCANGOS GEORGE A | Director | A Grant / award | 1,057 | $111.75 | +$118.1K |
| 2026-03-23 | SCANGOS GEORGE A | Director | A Grant / award | 2,158 | $111.75 | +$241.2K |
| 2026-03-23 | BRAWLEY OTIS W | Director | A Grant / award | 888 | $111.75 | +$99.2K |
| 2026-03-23 | BRAWLEY OTIS W | Director | A Grant / award | 2,158 | $111.75 | +$241.2K |
| 2026-03-23 | Rataj Sue H. | Director | A Grant / award | 2,158 | $111.75 | +$241.2K |
| 2026-03-03 | KIRKWOOD JONAH PREVOST | Senior Vice President | F Tax withholding | 124 | $121.38 | −$15.1K |
| 2026-03-03 | MCDONNELL PADRAIG | President and CEO | F Tax withholding | 279 | $121.38 | −$33.9K |
| 2026-03-03 | RIEMANN ANGELICA | Senior Vice President | F Tax withholding | 89 | $121.38 | −$10.8K |
| 2025-12-03 | Dolsten Mikael | Director | S Open-market sale | 2,600 | $149.81 | −$389.5K |
| 2025-12-01 | DiMarco Bret | Senior Vice President | F Tax withholding | 332 | $154.37 | −$51.3K |
| 2025-12-01 | KIRKWOOD JONAH PREVOST | Senior Vice President | F Tax withholding | 430 | $154.37 | −$66.4K |
| 2025-12-01 | MAY SIMON | Senior Vice President | F Tax withholding | 300 | $154.37 | −$46.3K |
| 2025-12-01 | MCDONNELL PADRAIG | President and CEO | F Tax withholding | 1,948 | $154.37 | −$300.7K |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-26upcoming | 1.49 | — | — |
| 2026-05-27 | 1.41 | 1.49 | +5.80% |
| 2026-02-25 | 1.37 | 1.36 | -0.60% |
| 2025-11-24 | 1.58 | 1.59 | +0.37% |
| 2025-08-27 | 1.37 | 1.37 | +0.17% |
| 2025-05-28 | 1.26 | 1.31 | +3.62% |
| 2025-02-26 | 1.27 | 1.31 | +2.99% |
| 2024-11-25 | 1.41 | 1.46 | +3.90% |
| 2024-08-21 | 1.26 | 1.32 | +4.93% |
| 2024-05-29 | 1.19 | 1.22 | +2.42% |
| 2024-02-27 | 1.23 | 1.29 | +4.68% |
| 2023-11-20 | 1.34 | 1.38 | +3.02% |
| 2023-08-15 | 1.37 | 1.43 | +4.55% |
| 2023-05-23 | 1.26 | 1.27 | +0.63% |
| 2023-02-28 | 1.31 | 1.37 | +4.46% |
| 2022-11-21 | 1.39 | 1.53 | +10.33% |